Joseph Gallegos

Joseph Gallegos is an experienced financial executive currently serving as the Chief Financial Officer at Legent Health since January 2024. With a robust background in financial leadership, Joseph held the position of Chief Financial Officer at Allergy & ENT Associates from February 2022 to January 2024, where responsibilities included overseeing financial operations, supporting growth and profitability, and engaging in mergers and acquisitions. Additional roles include Chief Financial Officer at Spring Fertility (January 2020 - January 2021) and West Dermatology (January 2019 - January 2020), along with being an investor at QuVa Pharma, Inc. since August 2015. Joseph holds a Master of Business Administration from the University of Houston's C.T. Bauer College of Business and has a strong track record in financial planning, revenue cycle management, and strategic growth initiatives across various healthcare sectors.